In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Periprocedural anticoagulation during AF ablation: can I use a NOAC?

EHRA webinar

25/02/2016 18:00 25/02/2016 19:00 Europe/Paris Periprocedural anticoagulation during AF ablation: can I use a NOAC?

Access event page

European Heart Rhythm Association DD/MM/YYYY
Stroke Prevention
Atrial Fibrillation

Focus on

After attending this webinar, participants will know:

The current scientific basis for the use of non-Vitamin K oral anticoagulants (NOAC)
The impact of the different NOACs on laboratory parameters for the assessment of anticoagulation
A regimen for “uninterrupted” peri-interventional use of NOACs
The management of peri-interventional bleeding complications
The latest on the current status of the antidotes idarucizumab (F.II inhibitors) and andexanet-alfa (F.Xa inhibitors)
The current evidence for the use of uninterrupted NOACs in the setting of catheter ablation


Watch the webinar recording



Prof. Philipp Sommer (host)

Prof. Richard Schilling (speaker)

Prof. Christian Sticherling (speaker)

Session information

Target audience: This webinar addresses EHRA members and cardiologists working in the field of arrhythmias.

During the webinar, you will be able to send your questions by chat and interact with our key opinion leaders who will provide feedback live.

Technical settings

The webinar is available on PC and Tablets. The use of a smartphone is not recommended. For the best viewing experience, a high-speed Internet connection is required (minimum 2Mbps). Please make sure that the firewall does not prevent the connection to the webinar.